Figure 3.
Forrest plot depicting the difference in 1- to 3-year survival probability between patients who received preoperative FOLFIRINOX versus gemcitabine and nab-paclitaxel (GA).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.